Symbol | Exchange | Currency |
|---|
By Oliver Gray Investing.com - The S&P/ASX 200 fell 91.5 points or 1.24% to 7312.2 in early trade, extending losses of 0.2% last week and trading at 9-week lows as falling Iron ore...
Feb 22 (Reuters) - Zelira Therapeutics Ltd ZLD.AX : * HY LOSS ATTRIBUTABLE $3.6 MILLION VERSUS LOSS OF $2.6 MILLION
Feb 15 (Reuters) - Zelira Therapeutics Ltd ZLD.AX : * OLUDARE ODUMOSU TO ASSUME ROLE OF GLOBAL MANAGING DIRECTOR * RICHARD HOPKINS TO STEP-DOWN AS CEO AND MANAGING DIRECTOR EX-USA
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Zelira Therapeutics Limited is an Australia-based cannabinoid-based biopharmaceutical company. It is focused on developing and clinically validating branded cannabinoid-based medicines for the treatment of a variety of medical conditions in its prescription (Rx) business, including insomnia, autism and chronic non-cancer pain. Its lead product, Zenivol, is a cannabinoid-based medicine for the treatment of chronic insomnia. It also provides formulations under the HOPE brand. The Company is engaged in human clinical trial programs focused on insomnia, autism and opioid reduction with activities in Australia and the United States. It is also focused on pre-clinical research examining the effects of cannabinoids in breast, brain and pancreatic cancer, as well as research and development of cannabinoids to treat diabetes-associated cognitive diseases. Its SprinjeneCBD toothpaste product is a hemp-derived, oral care product containing cannabinoids, based on the technology of blackseed oil.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Buy | Buy | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 49.62 | 49.95 | 49.38 | +0.280 | +0.57% | 1.54M | Sydney | |||
| 0.255 | 0.268 | 0.255 | -0.005 | -1.92% | 2.16M | Sydney | |||
| 0.013 | 0.013 | 0.013 | +0.001 | +8.33% | 238.49K | Sydney | |||
| 294.70 | 294.93 | 290.77 | -1.42 | -0.48% | 820.83K | Sydney | |||
| 17.50 | 17.56 | 17.33 | +0.20 | +1.16% | 2.45M | Sydney | |||
| 19.44 | 19.74 | 19.38 | +0.540 | +2.86% | 2.41M | Sydney | |||
| 0.034 | 0.035 | 0.032 | +0.001 | +3.03% | 566.94K | Sydney | |||
| 0.945 | 0.95 | 0.92 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 3.42 | 3.68 | 3.38 | -0.140 | -3.93% | 446.61K | Sydney | |||
| 2.47 | 2.51 | 2.41 | -0.040 | -1.59% | 694.40K | Sydney | |||
| 66.69 | 66.84 | 65.67 | -0.61 | -0.91% | 487.70K | Sydney | |||
| 0.68 | 0.70 | 0.67 | +0.01 | +2.27% | 10.50M | Sydney | |||
Duluxgroupderived | 0.022 | 0.02 | 9.35 | 0.00 | 0.00% | 0.00 | Sydney | ||
| 36.42 | 37.70 | 36.42 | -0.890 | -2.39% | 5.36M | Sydney | |||
| 1.84 | 1.85 | 1.73 | +0.12 | +7.29% | 611.54K | Sydney |